AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15124952 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 42
Study 11818767 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (10 microg x kg(‐1) administered over 5 min + 5 microg x kg(‐1) x h(‐1) intravenous) given before mu-opioid receptor blockade
Number of subjects: 14
Study 11818767 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (10 microg x kg(‐1) administered over 5 min + 5 microg x kg(‐1) x h(‐1) intravenous) given after mu-opioid receptor blockade
Number of subjects: 14
Study 11818767 — intervention group
Group type: COMPARATOR
Intervention: Mu-opioid receptor blockade (naloxone)
Number of subjects: 14
Study 9561877 — intervention group
Group type: EXPERIMENTAL
Intervention: DDD pacing from ventricular apex
Number of subjects: 21
Study 9561877 — intervention group
Group type: EXPERIMENTAL
Intervention: DDD pacing from right ventricular outflow tract (RVOT)
Number of subjects: 21
Study 9561877 — intervention group
Group type: EXPERIMENTAL
Intervention: DDD pacing from proximal septum (His bundle area)
Number of subjects: 21
Study 9561877 — intervention group
Group type: COMPARATOR
Intervention: Control group (apical pacing)
Number of subjects: 21
Study 7655204 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepivacaine 2% (4 ml)
Number of subjects: 34
Study 7655204 — intervention group
Group type: EXPERIMENTAL
Intervention: Prilocaine 2% (4 ml)
Number of subjects: 34
Study 7655204 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 2% (4 ml)
Number of subjects: 34
Study 2698273 — intervention group
Group type: EXPERIMENTAL
Intervention: Amineptine 200 mg/day
Number of subjects: 40
Study 2698273 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 1099948 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled atropine sulfate
Number of subjects: 15
Study 1099948 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled isoproterenol hydrochloride
Number of subjects: 15
Study 1099948 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 31003683 — intervention group
Group type: EXPERIMENTAL
Intervention: One massage per week for two weeks
Number of subjects: 38
Study 31003683 — intervention group
Group type: EXPERIMENTAL
Intervention: Three massages per week for two weeks
Number of subjects: 38
Study 28704487 — intervention group
Group type: EXPERIMENTAL
Intervention: PRETmax
Number of subjects: 20
Study 28704487 — intervention group
Group type: COMPARATOR
Intervention: RAMP
Number of subjects: 20
Study 28704487 — intervention group
Group type: COMPARATOR
Intervention: PRETmax vs RAMP
Number of subjects: 20
Study 26351969 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline hydrochloride, 50 to 100 mg/d
Number of subjects: 252
Study 26351969 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 252
Study 23432534 — intervention group
Group type: EXPERIMENTAL
Intervention: Netazepide (1, 5, 25, and 100 mg)
Number of subjects: 18
Study 23432534 — intervention group
Group type: EXPERIMENTAL
Intervention: Netazepide (100 mg) twice daily for 13 doses
Number of subjects: 18
Study 23432534 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 21292928 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 160
Study 21292928 — intervention group
Group type: COMPARATOR
Intervention: Chlorpromazine
Number of subjects: 160
Study 19922726 — intervention group
Group type: EXPERIMENTAL
Intervention: N-A (non-adherent, knitted, viscose filament gauze)
Number of subjects: 229
Study 19922726 — intervention group
Group type: EXPERIMENTAL
Intervention: Inadine (iodine-impregnated dressing)
Number of subjects: 229
Study 19922726 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquacel (newer product)
Number of subjects: 229
Study 19922726 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-adherent dressings
Number of subjects: 229
Study 19922726 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 229
Study 16447938 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous serum eye drops
Number of subjects: 27
Study 16447938 — intervention group
Group type: COMPARATOR
Intervention: Artificial tears
Number of subjects: 27
Study 15648125 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress management training
Number of subjects: 43
Study 15648125 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 43
Study 11737510 — intervention group
Group type: EXPERIMENTAL
Intervention: CHX 0.2% + alcohol (Corsodyl)
Number of subjects: 16
Study 11737510 — intervention group
Group type: EXPERIMENTAL
Intervention: CHX 0.12% + alcohol (Perio.Aid)
Number of subjects: 16
Study 11737510 — intervention group
Group type: COMPARATOR
Intervention: CHX 0.12% + sodium fluoride 0.05% (Cariax Gingival)
Number of subjects: 16
Study 11737510 — intervention group
Group type: EXPERIMENTAL
Intervention: CHX 0.12% + CPC 0.05% (Perio.Aid, new formulation)
Number of subjects: 16
Study 8989272 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg ALN daily
Number of subjects: 359
Study 8989272 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg ALN daily
Number of subjects: 359
Study 8989272 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.0 mg ALN daily
Number of subjects: 359
Study 8989272 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 359
Study 8989272 — intervention group
Group type: EXPERIMENTAL
Intervention: ALN (1.0, 2.5, or 5.0 mg)
Number of subjects: 359
Study 8500697 — intervention group
Group type: COMPARATOR
Intervention: Sham feeding (without intubation)
Number of subjects: 8
Study 8500697 — intervention group
Group type: COMPARATOR
Intervention: Sham feeding (with intubation)
Number of subjects: 8
Study 8500697 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral meals
Number of subjects: 8
Study 8500697 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric emptying of solids
Number of subjects: 8
Study 3303293 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate (Andapsin 1g X 4)
Number of subjects: 371
Study 3303293 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine (Tagamet 400mg X 2)
Number of subjects: 371
Study 3303293 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (Sucralfate and Cimetidine)
Number of subjects: 371
Study 29775553 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT) administered in one upper quadrant (wavelength: 660 nm; Power: 100 mW; Power density: 100 mW/cm2; Energy density per application point = 2 J/cm2; Total dose = 52 J/cm2; Irradiation time: 26 × 20 sec)
Number of subjects: 13
Study 29775553 — intervention group
Group type: COMPARATOR
Intervention: Simulated laser application (control)
Number of subjects: 13
Study 27178897 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure lowering (target SBP <140 mm Hg)
Number of subjects: 3184
Study 27178897 — intervention group
Group type: COMPARATOR
Intervention: Guideline-based blood pressure management (SBP <180 mm Hg)
Number of subjects: 3184
Study 27178897 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithrombotic-associated ICH
Number of subjects: 3184
Study 27178897 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up CT after 24 hours
Number of subjects: 3184
Study 24517720 — intervention group
Group type: COMPARATOR
Intervention: Intravaginal progesterone gel (Crinone 8% gel)
Number of subjects: 95
Study 24517720 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal progesterone plus oral 2 mg estradiol hemihydrate (E2)
Number of subjects: 95
Study 24517720 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal progesterone plus oral 6 mg estradiol hemihydrate (E2)
Number of subjects: 95
Study 22470429 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg/d
Number of subjects: 30
Study 22470429 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg/d
Number of subjects: 30
Study 22470429 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 30
Study 21103404 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill exercise testing
Number of subjects: 519
Study 21103404 — intervention group
Group type: EXPERIMENTAL
Intervention: Constant work rate tests at 61 ± 33 watts
Number of subjects: 519
Study 21103404 — intervention group
Group type: EXPERIMENTAL
Intervention: Second constant work rate test
Number of subjects: 519
Study 18502362 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole
Number of subjects: 21
Study 18502362 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 14758215 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthesis method
Number of subjects: 30
Study 14758215 — intervention group
Group type: COMPARATOR
Intervention: Open palm technique
Number of subjects: 30
Study 14758215 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study 11700410 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP) 15 mg/kg
Number of subjects: 39
Study 11700410 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirilazad mesylate (TM) 10 mg/kg
Number of subjects: 39
Study 11700410 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 39
Study 9152745 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 min aerobic exercise at 50% VO2 max with a low-fat diet (mean FO = 0.89)
Number of subjects: 6
Study 9152745 — intervention group
Group type: COMPARATOR
Intervention: Rest with a mixed diet (mean FQ = 0.85)
Number of subjects: 6
Study 7697692 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin-glipizide (5 mg/d)
Number of subjects: 70
Study 7697692 — intervention group
Group type: COMPARATOR
Intervention: Insulin-placebo
Number of subjects: 70
Study 3316301 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiapamil 300 to 600 mg bid
Number of subjects: 30
Study 3316301 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCTZ) 25 to 50 mg bid
Number of subjects: 30
Study 31223150 — intervention group
Group type: EXPERIMENTAL
Intervention: In-class quiz
Number of subjects: 0
Study 31223150 — intervention group
Group type: EXPERIMENTAL
Intervention: Practicum
Number of subjects: 0
Study 31223150 — intervention group
Group type: EXPERIMENTAL
Intervention: Trading Places exercise
Number of subjects: 0
Study 31223150 — intervention group
Group type: EXPERIMENTAL
Intervention: Cultural competency curriculum elements (practicum, lecture, Worlds Apart videos)
Number of subjects: 0
Study 31223150 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall teaching methods
Number of subjects: 0
Study 31223150 — intervention group
Group type: EXPERIMENTAL
Intervention: Grades improvement
Number of subjects: 0
Study 29731633 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-monthly paliperidone palmitate initiated </=1 week after hospitalization
Number of subjects: 0
Study 29731633 — intervention group
Group type: COMPARATOR
Intervention: Once-monthly paliperidone palmitate initiated >1 week after hospitalization
Number of subjects: 0
Study 26847169 — intervention group
Group type: EXPERIMENTAL
Intervention: Platform switching
Number of subjects: 63
Study 26847169 — intervention group
Group type: COMPARATOR
Intervention: Platform matching
Number of subjects: 63
Study 26847169 — intervention group
Group type: COMPARATOR
Intervention: Comparison between platform switching and platform matching
Number of subjects: 63
Study 24514085 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftobiprole
Number of subjects: 251
Study 22997786 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion treatment (suspended moxibustion applied to Yanglingquan for 15 min, massage device used on pain area, self-help or mutual-aid treatment)
Number of subjects: 58
Study 22997786 — intervention group
Group type: COMPARATOR
Intervention: Plaster application (Goupi Gao applied to local pain area, treatment once daily for 5 days)
Number of subjects: 58
Study 20129478 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive telephone breastfeeding support (2 weeks of daily calls by nurses)
Number of subjects: 341
Study 20129478 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive telephone breastfeeding support
Number of subjects: 341
Study 20129478 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 341
Study 17534702 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-form FCE
Number of subjects: 372
Study 17534702 — intervention group
Group type: COMPARATOR
Intervention: Standard FCE
Number of subjects: 372
Study 16337459 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate nasal spray (MFNS) 200 microg once daily
Number of subjects: 354
Study 16337459 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate nasal spray (MFNS) 200 microg twice daily
Number of subjects: 354
Study 16337459 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 354
Study 11213273 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative primary care model
Number of subjects: 0
Study 11213273 — intervention group
Group type: COMPARATOR
Intervention: Comparison clinics (control)
Number of subjects: 0
Study 9429370 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental groups (specific interventions not detailed)
Number of subjects: 67
Study 9429370 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 67
Study 8236580 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin injections during the first and second postoperative day
Number of subjects: 22
Study 8236580 — intervention group
Group type: COMPARATOR
Intervention: Placebo injections during the first and second postoperative day
Number of subjects: 22
Study 3655008 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline
Number of subjects: 0
Study 3655008 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31153628 — intervention group
Group type: EXPERIMENTAL
Intervention: Transmuscular quadratus lumborum (TQL) block with ropivacaine 0.75%, 30 ml
Number of subjects: 60
Study 31153628 — intervention group
Group type: COMPARATOR
Intervention: Saline 30 ml (control)
Number of subjects: 60
Study 28939617 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment (SBP<120 mm Hg)
Number of subjects: 13946
Study 28939617 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (SBP<140 mm Hg)
Number of subjects: 13946
Study 26759107 — intervention group
Group type: EXPERIMENTAL
Intervention: First line treatment in therapy group
Number of subjects: 405
Study 26759107 — intervention group
Group type: COMPARATOR
Intervention: Observation group
Number of subjects: 405
Study 24391801 — intervention group
Group type: EXPERIMENTAL
Intervention: ART with concurrent active TB
Number of subjects: 1571
Study 24391801 — intervention group
Group type: EXPERIMENTAL
Intervention: ART with other non-TB AIDS-defining disease
Number of subjects: 1571
Study 24391801 — intervention group
Group type: COMPARATOR
Intervention: ART without concurrent TB or other AIDS-defining disease
Number of subjects: 1571
Study 21189401 — intervention group
Group type: EXPERIMENTAL
Intervention: benazepril plus amlodipine
Number of subjects: 573
Study 21189401 — intervention group
Group type: COMPARATOR
Intervention: benazepril plus hydrochlorothiazide
Number of subjects: 573
Study 18566886 — intervention group
Group type: EXPERIMENTAL
Intervention: Study Group (SG) - preoperative and postoperative education programs, home visits from outpatient team
Number of subjects: 50
Study 18566886 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) - conventional rehabilitation, possible stay at rehabilitation center
Number of subjects: 50
Study 18566886 — intervention group
Group type: EXPERIMENTAL
Intervention: Study Group (SG)
Number of subjects: 50
Study 16580903 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (0.075 mg/kg)
Number of subjects: 19
Study 16580903 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (40 mg)
Number of subjects: 19
Study 16580903 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam and Simvastatin correlation
Number of subjects: 19
Study 16580903 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam and Simvastatin AUC inhibitory ratio
Number of subjects: 19
Study 14608317 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic‐assisted bilateral buttress plate fixation
Number of subjects: 18
Study 10683436 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated linoleic acid (CLA) 4.2 g/day for 3 months
Number of subjects: 0
Study 10683436 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 9081102 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific inspiratory muscle training and incentive spirometry, 1 hour per day, six times a week, for 2 weeks before and 3 months after lung resection (group A)
Number of subjects: 32
Study 9081102 — intervention group
Group type: COMPARATOR
Intervention: No training (group B)
Number of subjects: 32
Study 9081102 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific inspiratory muscle training and incentive spirometry (group A)
Number of subjects: 32
Study 8147043 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified orthostatic test during pregnancy
Number of subjects: 161
Study 31718542 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal training programme (MTP) with Integrated Brief Systemic Therapy (IBST) approach
Number of subjects: 38
Study 31718542 — intervention group
Group type: COMPARATOR
Intervention: Routine clinical Mental health support programme for primary care (Control)
Number of subjects: 38
Study 29618548 — intervention group
Group type: EXPERIMENTAL
Intervention: Insect-fungus interaction networks
Number of subjects: 0
Study 29618548 — intervention group
Group type: EXPERIMENTAL
Intervention: Wood-decay fungi interactions
Number of subjects: 0
Study 29618548 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant pathogenic fungi interactions
Number of subjects: 0
Study 29618548 — intervention group
Group type: EXPERIMENTAL
Intervention: Insect symbiont fungi interactions
Number of subjects: 0
Study 26921473 — intervention group
Group type: EXPERIMENTAL
Intervention: Bag-valve ventilation
Number of subjects: 30
Study 26921473 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask (LMA)
Number of subjects: 30
Study 26921473 — intervention group
Group type: EXPERIMENTAL
Intervention: I-Gel
Number of subjects: 30
Study 26921473 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Tube (LT)
Number of subjects: 30
Study 26921473 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotracheal Intubation (ETI)
Number of subjects: 30
Study 26921473 — intervention group
Group type: EXPERIMENTAL
Intervention: EasyTube
Number of subjects: 30
Study 24710760 — intervention group
Group type: EXPERIMENTAL
Intervention: Colesevelam 3.75 g/day
Number of subjects: 357
Study 24710760 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 357
Study 22277987 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal 17β‐estradiol plus cyclical micronized progesterone for 3 months
Number of subjects: 84
Study 22277987 — intervention group
Group type: COMPARATOR
Intervention: Control group (no hormone therapy)
Number of subjects: 84
Study 20350191 — intervention group
Group type: EXPERIMENTAL
Intervention: MVA (ACAM3000) administered intradermally at 1 x 10(7) TCID(50)
Number of subjects: 72
Study 20350191 — intervention group
Group type: EXPERIMENTAL
Intervention: MVA (ACAM3000) administered intramuscularly or subcutaneously at 1 x 10(8) TCID(50)
Number of subjects: 72
Study 20350191 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 18702944 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive oil rich in oleic acid (18:1n‐9)
Number of subjects: 15
Study 18702944 — intervention group
Group type: COMPARATOR
Intervention: Sunflower oil rich in linoleic acid (18:2n‐6)
Number of subjects: 15
Study 18702944 — intervention group
Group type: COMPARATOR
Intervention: Flaxseed oil rich in linolenic acid (18:3n‐3)
Number of subjects: 15
Study 15945400 — intervention group
Group type: EXPERIMENTAL
Intervention: promethazine 25 mg
Number of subjects: 21
Study 15945400 — intervention group
Group type: EXPERIMENTAL
Intervention: meclizine 50 mg
Number of subjects: 21
Study 15945400 — intervention group
Group type: EXPERIMENTAL
Intervention: dimenhydrinate 50 mg
Number of subjects: 21
Study 15945400 — intervention group
Group type: EXPERIMENTAL
Intervention: promethazine 25 mg plus pseudoephedrine 60 mg
Number of subjects: 21
Study 15945400 — intervention group
Group type: EXPERIMENTAL
Intervention: promethazine 25 mg plus d‐amphetamine 10 mg
Number of subjects: 21
Study 15945400 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 21
Study 12841887 — intervention group
Group type: COMPARATOR
Intervention: Levormeloxifene (four different doses) for 12 months
Number of subjects: 381
Study 12841887 — intervention group
Group type: COMPARATOR
Intervention: Raloxifene (three different doses) for 24 months
Number of subjects: 381
Study 12841887 — intervention group
Group type: COMPARATOR
Intervention: Placebo for both studies
Number of subjects: 381
Study 10597781 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream
Number of subjects: 100
Study 10597781 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 100
Study 8598506 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin supplementation
Number of subjects: 180
Study 8598506 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study 8598506 — intervention group
Group type: COMPARATOR
Intervention: Hawthorne effect
Number of subjects: 180
Study 8598506 — intervention group
Group type: COMPARATOR
Intervention: Natural history
Number of subjects: 180
Study 1745622 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen 1000 mg
Number of subjects: 0
Study 1745622 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen 2000 mg
Number of subjects: 0
Study 1745622 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen 1000 mg plus codeine phosphate 60 mg (APAPCOD)
Number of subjects: 0
Study 1745622 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 0
Study 6285814 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole after fasting (200 mg)
Number of subjects: 10
Study 6285814 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole after standardized meal (660 kilocalories) (brand 1)
Number of subjects: 10
Study 6285814 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole with orange juice (300 ml) (brand 1)
Number of subjects: 10